RYAH Group, Inc. announced that it has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers for use in a pilot study to be conducted by Four 20 Pharma GmbH in preparation for a wider distribution strategy for the RYAH Smart Dry-Herb Inhaler and data analytics platform in the German market. Four 20 is expected to sponsor a launch of an observational study using the RYAH Dry-Herb Inhalers in order to collect accurate patient feedback on consumption of cannabis strains for elder care patients and other patient demographics.